Your browser doesn't support javascript.
loading
Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting.
Aristei, Cynthia; Bölükbasi, Yasemin; Kaidar-Person, Orit; Pfeffer, Raphael; Arenas, Meritxell; Boersma, Liesbeth J; Ciabattoni, Antonella; Coles, Charlotte E; Franco, Pierfrancesco; Krengli, Marco; Leonardi, Maria Cristina; Marazzi, Fabio; Masiello, Valeria; Meattini, Icro; Montero, Angel; Offersen, Birgitte; Trigo, Maria Lurdes; Bourgier, Céline; Genovesi, Domenico; Kouloulias, Vassilis; Morganti, Alessio G; Meduri, Bruno; Pasinetti, Nadia; Pedretti, Sara; Perrucci, Elisabetta; Rivera, Sofia; Tombolini, Vincenzo; Vidali, Cristiana; Valentini, Vincenzo; Poortmans, Philip.
Afiliación
  • Aristei C; Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia and Perugia General Hospital, Perugia, Italy. Electronic address: cynthia.aristei@unipg.it.
  • Bölükbasi Y; Koc University, Faculty of Medicine, Department of Radiation Oncology, Istanbul, Turkey.
  • Kaidar-Person O; Breast Radiation Unit, Radiation Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Pfeffer R; Oncology Institute, Assuta Medical Center, Tel Aviv and Ben Gurion University Medical School, Israel.
  • Arenas M; Universitat Rovira I Virgili, Radiation Oncology Department, Hospital Universitari Sant Hoan de Reus, IISPV, Spain.
  • Boersma LJ; Radiation Oncology (Maastro), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Ciabattoni A; Department of Radiation Oncology, San Filippo Neri Hospital, ASL Rome 1, Rome, Italy.
  • Coles CE; Department of Oncology, University of Cambridge, UK.
  • Franco P; Depatment of Translational Medicine, University of Eastern Piedmont and Department of Radiation Oncology, 'Maggiore della Carità' University Hospital, Novara, Italy.
  • Krengli M; Depatment of Translational Medicine, University of Eastern Piedmont and Department of Radiation Oncology, 'Maggiore della Carità' University Hospital, Novara, Italy.
  • Leonardi MC; Division of Radiation Oncology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Marazzi F; Unità Operativa di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagine, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Gemelli IRCSS Roma, Italy.
  • Masiello V; Unità Operativa di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagine, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Gemelli IRCSS Roma, Italy.
  • Meattini I; Department of Experimental and Clinical Biomedical Sciences "M. Serio", University of Florence & Radiation Oncology Unit - Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
  • Montero A; Department of Radiation Oncology, University Hospital HM Sanchinarro, HM Hospitales, Madrid, Spain.
  • Offersen B; Department of Experimental Clinical Oncology, Department of Oncology, Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Trigo ML; Service of Brachytherapy, Department of Image and Radioncology, Instituto Português Oncologia Porto Francisco Gentil E.P.E., Portugal.
  • Bourgier C; Radiation Oncology, ICM-Val d'Aurelle, Univ Montpellier, Montpellier, France.
  • Genovesi D; Radiation Oncology, Ospedale Clinicizzato Chieti and University "G. d'Annunzio", Chieti, Italy.
  • Kouloulias V; 2nd Department of Radiology, Radiotherapy Unit, Medical School, National and Kapodistrian University of Athens, Greece.
  • Morganti AG; DIMES, Alma Mater Studiorum Bologna University, Bologna, Italy; Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Alma Mater Studiorum Bologna University; Bologna, Italy.
  • Meduri B; Radiation Oncology Unit, University Hospital of Modena, Modena, Italy.
  • Pasinetti N; Radiation Oncology Service, ASST Valcamonica Esine and Brescia University, Brescia, Italy.
  • Pedretti S; Istituto del Radio "O.Alberti" - Spedali Civili Hospital and Brescia University, Brescia.
  • Perrucci E; Radiation Oncology Section, Perugia General Hospital, Perugia, Italy.
  • Rivera S; Radiation Oncology, Institut Gustave Roussy, Villejuif, France.
  • Tombolini V; Radiation Oncology, Department of Radiological, Oncological and Pathological Science, University "La Sapienza", Roma, Italy.
  • Vidali C; Former Senior Assistant Department of Radiation Oncology, Azienda Sanitaria Universitaria Integrata di Trieste, Trieste, Italy.
  • Valentini V; Division of Radiation Oncology, IEO European Institute of Oncology, IRCCS, Milan, Italy.
  • Poortmans P; Department of Radiation Oncology, Iridium Kankernetwerk, Antwerp, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium.
Crit Rev Oncol Hematol ; 177: 103774, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35917884
ABSTRACT
We report on the third Assisi Think Tank Meeting (ATTM) on breast cancer, a brainstorming project which involved European radiation and clinical oncologists who were dedicated to breast cancer research and treatment. Held on February 2020, the ATTM aimed at identifying key clinical questions in current clinical practice and "grey" areas requiring research to improve management and outcomes. Before the meeting, three key topics were selected 1) managing patients with frailty due to either age and/or multi-morbidity; 2) stereotactic radiation therapy and systemic therapy in the management of oligometastatic disease; 3) contralateral breast tumour prevention in BCRA-mutated patients. Clinical practice in these areas was investigated by means of an online questionnaire. In the lapse period between the survey and the meeting, the working groups reviewed data, on-going studies and the clinical challenges which were then discussed in-depth and subjected to intense brainstorming during the meeting; research protocols were also proposed. Methodology, outcome of discussions, conclusions and study proposals are summarized in the present paper. In conclusion, this report presents an in-depth analysis of the state of the art, grey areas and controversies in breast cancer radiation therapy and discusses how to confront them in the absence of evidence-based data to guide clinical decision-making.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Female / Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Mama Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Female / Humans Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2022 Tipo del documento: Article